H. Winkler and R. Fischer-colbrie, The chromogranins A and B: The first 25 years and future perspectives, Neuroscience, vol.49, issue.3, pp.497-528, 1992.
DOI : 10.1016/0306-4522(92)90222-N

A. Fahrenkamp, C. Wibbeke, G. Winde, D. Ofner, W. Bocker et al., Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract, Virchows Archiv, vol.426, issue.4, pp.361-367, 1995.
DOI : 10.1007/BF00191345

L. Gall, F. Vallet, V. Thomas, D. , D. Monti et al., Immunohistochemical study of secretogranin II in 62 neuroendocrine tumours of the digestive tract and of the pancreas in comparison with other granins, Pathol Res Pract, vol.193, pp.179-185, 1997.

R. Prommegger, P. Obrist, C. Ensinger, H. Schwelberger, C. Wolf et al., Secretoneurin in carcinoids of the appendix-immunohistochemical comparison with chromogranins A, B and secretogranin II, Anticancer Res, vol.18, pp.3999-4002, 1998.

V. Vallet, J. Li, and J. Duval, Secretogranin II (SgII) distribution and processing studies in human normal and adenomatous anterior pituitaries using new polyclonal antibodies, Regulatory Peptides, vol.68, issue.3, pp.155-163, 1997.
DOI : 10.1016/S0167-0115(96)02110-6

U. Eder, R. Fischer-colbrie, P. Kogner, B. Leitner, P. Bjellerup et al., Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas, Neuroscience Letters, vol.253, issue.1, pp.17-20, 1998.
DOI : 10.1016/S0304-3940(98)00588-6

R. Cunningham, K. Pogue, W. Curry, C. Johnston, J. Sloan et al., Immunostaining for vasostatin I distinguishes between ileal and lung carcinoids, The Journal of Pathology, vol.381, issue.3, pp.321-325, 1999.
DOI : 10.7326/0003-4819-120-4-199402150-00008

R. Ischia, R. Gasser, R. Fischer-colbrie, U. Eder, A. Pagani et al., Levels and Molecular Properties of Secretoneurin-Immunoreactivity in the Serum and Urine of Control and Neuroendocrine Tumor Patients, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.1, pp.355-360, 2000.
DOI : 10.1210/jc.85.1.355

R. Ischia, A. Hobisch, R. Bauer, U. Weiss, R. Gasser et al., ELEVATED LEVELS OF SERUM SECRETONEURIN IN PATIENTS WITH THERAPY RESISTANT CARCINOMA OF THE PROSTATE, The Journal of Urology, vol.163, issue.4, pp.1161-1164, 2000.
DOI : 10.1016/S0022-5347(05)67714-2

U. Laemmli, Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4, Nature, vol.244, issue.5259, pp.680-685, 1970.
DOI : 10.1101/SQB.1963.028.01.053

K. Schmid, B. Kunk, R. Kirchmair, M. Tö-tsch, W. Bö-cker et al., Immunohistochemical detection of secretoneurin, a novel neuropeptide endoproteolytically processed from secretogranin II, in normal human endocrine and neuronal tissues, The Histochemical Journal, vol.18, issue.6, pp.473-481, 1995.
DOI : 10.1016/0016-5085(88)90374-5

M. Schober, R. Fischer-colbrie, K. Schmid, G. Bussolati, O. Connor et al., Comparison of chromogranin A, B, and secretogranin II in human adrenal medulla and pheochromocytoma, Lab Invest, vol.57, pp.385-391, 1987.

K. Schmid, B. Dockhorn-dworniczak, M. Kirchmair, R. Fischer-colbrie, W. Bocker et al., Chromogranin A, secretogranin II and vasoactive intestinal peptide in phaeochromocytomas and ganglioneuromas, Histopathology, vol.15, issue.6, pp.527-533, 1993.
DOI : 10.1007/BF01675753

K. Schmid, R. Fischer-colbrie, C. Hagn, B. Jasani, E. Williams et al., Chromogranin A and B and Secretogranin II in Medullary Carcinomas of the Thyroid, The American Journal of Surgical Pathology, vol.11, issue.7, pp.551-556, 1987.
DOI : 10.1097/00000478-198707000-00007

R. Weiler, H. Feichtinger, K. Schmid, R. Fischer-colbrie, L. Grimelius et al., Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids, Virchows Archiv A Pathological Anatomy and Histopathology, vol.87, issue.2, pp.103-109, 1987.
DOI : 10.1093/ajcp/84.3.273

E. Baudin, J. Bidart, A. Bachelot, M. Ducreux, D. Elias et al., Impact of chromogranin A measurement in the work-up of neuroendocrine tumors, Annals of Oncology, vol.12, issue.2suppl, pp.79-82, 2001.
DOI : 10.1023/A:1012494309486

R. Hsiao, R. Seeger, A. Yu, and O. , Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival., Journal of Clinical Investigation, vol.85, issue.5, pp.1555-1559
DOI : 10.1172/JCI114604

P. Kogner, P. Bjellerup, T. Svensson, and E. Theodorsson, Pancreastatin immunoreactivity in favourable chilhood neuroblastoma and ganglioneuroma, 1995.

, Eur J Cancer, vol.31, pp.557-560

L. Thompson, Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms, The American Journal of Surgical Pathology, vol.26, issue.5, pp.551-566, 2002.
DOI : 10.1097/00000478-200205000-00002

F. Rao, H. Keiser, O. Connor, and D. , Malignant Pheochromocytoma : Chromaffin Granule Transmitters and Response to Treatment, Hypertension, vol.36, issue.6, pp.1045-1052, 2000.
DOI : 10.1161/01.HYP.36.6.1045

E. Van-der-harst, H. Bruining, J. Bonger, H. Van-der-ham, F. Dinjens et al., Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?, Proliferative index in phaechromocytomas: does it predict the occurrence of metastases, pp.175-180, 2000.
DOI : 10.1002/(SICI)1097-0215(19981023)79:5<537::AID-IJC16>3.0.CO;2-Z

H. John, W. Ziegler, D. Hauri, and P. Jaeger, Pheochromocytomas: can malignant potential be predicted?, Urology, vol.53, issue.4, pp.679-683, 1999.
DOI : 10.1016/S0090-4295(98)00612-8

M. Clarke, R. Weyant, C. Watson, and S. Carty, Prognostic markers in pheochromocytoma, Prognostic markers in pheochromocytoma, pp.522-526, 1998.
DOI : 10.1016/S0046-8177(98)90070-3

S. Nagura, R. Katoh, M. Kobayashi, T. Obara, and K. Omata, Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas, Mod Pathol, vol.12, pp.1107-1111, 1999.